There is no real consumer protection for kūpuna facing selling their units, draining their savings or taking on debt.
Based on the feedback from the FDA, the Company’s regulatory data package would be sufficient for the submission of an NDA for AXS-12 for the treatment of cataplexy in narcolepsy. Axsome anticipates ...
With 2025 drawing to a close, Known Time Traveller and Fark.com founder Drew Curtis claims the title 'The Living Oddstradamus ...